Vanguard Group’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-285,154
| Closed | -$60K | – | 4243 |
|
|
2018
Q3 | $60K | Hold |
285,154
| – | – | ﹤0.01% | 4112 |
|
|
2018
Q2 | $74K | Buy |
285,154
+205,588
| +258% | +$53.4K | ﹤0.01% | 4079 |
|
|
2018
Q1 | $20K | Buy |
+79,566
| New | +$22K | ﹤0.01% | 4089 |
|
|
2017
Q4 | – | Sell |
-62,760
| Closed | -$23K | – | 4160 |
|
|
2017
Q3 | $23K | Sell |
62,760
-617
| -1% | -$300 | ﹤0.01% | 4056 |
|
|
2017
Q2 | $55K | Buy |
63,377
+7,700
| +14% | +$12.6K | ﹤0.01% | 4022 |
|
|
2017
Q1 | $177K | Sell |
55,677
-5,034
| -8% | -$13.1K | ﹤0.01% | 3921 |
|
|
2016
Q4 | $125K | Buy |
60,711
+8,483
| +16% | +$26.9K | ﹤0.01% | 3957 |
|
|
2016
Q3 | $246K | Sell |
52,228
-11,744
| -18% | -$75.6K | ﹤0.01% | 3870 |
|
|
2016
Q2 | $589K | Hold |
63,972
| – | – | ﹤0.01% | 3754 |
|
|
2016
Q1 | $742K | Sell |
63,972
-337
| -0.5% | -$3.79K | ﹤0.01% | 3681 |
|
|
2015
Q4 | $914K | Buy |
64,309
+267
| +0.4% | +$4.41K | ﹤0.01% | 3655 |
|
|
2015
Q3 | $1.08M | Buy |
64,042
+686
| +1% | +$12.5K | ﹤0.01% | 3609 |
|
|
2015
Q2 | $1.2M | Buy |
63,356
+2,700
| +4% | +$52K | ﹤0.01% | 3613 |
|
|
2015
Q1 | $1.18M | Buy |
60,656
+16,940
| +39% | +$425K | ﹤0.01% | 3589 |
|
|
2014
Q4 | $1.28M | Buy |
43,716
+1,430
| +3% | +$41.2K | ﹤0.01% | 3445 |
|
|
2014
Q3 | $1.5M | Buy |
42,286
+990
| +2% | +$38.1K | ﹤0.01% | 3374 |
|
|
2014
Q2 | $1.85M | Hold |
41,296
| – | – | ﹤0.01% | 3288 |
|
|
2014
Q1 | $2.02M | Buy |
41,296
+4,594
| +13% | +$225K | ﹤0.01% | 3220 |
|
|
2013
Q4 | $1.36M | Buy |
36,702
+2,679
| +8% | +$254K | ﹤0.01% | 3329 |
|
|
2013
Q3 | $3.5M | Buy |
34,023
+7,600
| +29% | +$834K | ﹤0.01% | 2918 |
|
|
2013
Q2 | $2.05M | Buy |
+26,423
| New | +$2.53M | ﹤0.01% | 3057 |
|